BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
26.30
-0.22 (-0.83%)
At close: Oct 7, 2025, 4:00 PM EDT
25.78
-0.52 (-1.98%)
After-hours: Oct 7, 2025, 6:58 PM EDT
BioLife Solutions Market Cap
BioLife Solutions has a market cap or net worth of $1.26 billion as of October 7, 2025. Its market cap has increased by 6.17% in one year.
Market Cap
1.26B
Enterprise Value
1.18B
1-Year Change
6.17%
Ranking
Category
Stock Price
$26.30
Market Cap Chart
Since December 1, 1998, BioLife Solutions's market cap has increased from $4.30M to $1.26B, an increase of 29,200.20%. That is a compound annual growth rate of 23.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 6, 2025 | 1.27B | 5.50% |
Dec 31, 2024 | 1.20B | 68.30% |
Dec 29, 2023 | 715.50M | -8.07% |
Dec 30, 2022 | 778.30M | -49.86% |
Dec 31, 2021 | 1.55B | 18.87% |
Dec 31, 2020 | 1.31B | 294.62% |
Dec 31, 2019 | 330.90M | 48.65% |
Dec 31, 2018 | 222.60M | 172.13% |
Dec 29, 2017 | 81.80M | 295.17% |
Dec 30, 2016 | 20.70M | -22.18% |
Dec 31, 2015 | 26.60M | 34.34% |
Dec 31, 2014 | 19.80M | -53.08% |
Dec 31, 2013 | 42.20M | 78.06% |
Dec 31, 2012 | 23.70M | 577.14% |
Dec 30, 2011 | 3.50M | -16.67% |
Dec 31, 2010 | 4.20M | -45.45% |
Dec 31, 2009 | 7.70M | 266.67% |
Dec 31, 2008 | 2.10M | -50.00% |
Dec 31, 2007 | 4.20M | -12.50% |
Dec 29, 2006 | 4.80M | 220.00% |
Dec 30, 2005 | 1.50M | 36.36% |
Dec 31, 2004 | 1.10M | -21.43% |
Dec 31, 2003 | 1.40M | -6.67% |
Dec 31, 2002 | 1.50M | -42.31% |
Dec 31, 2001 | 2.60M | -57.38% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 757.36B |
Johnson & Johnson | 454.91B |
AbbVie | 411.31B |
UnitedHealth Group | 329.36B |
AstraZeneca | 266.44B |
Novo Nordisk | 261.01B |
Novartis AG | 255.35B |
Abbott Laboratories | 231.52B |